Measures of cholesterol concentration in 72 participants treated
with three different drugs. The aim is to examine the potential of new class
of drugs in lowering the cholesterol concentration and consequently reducing
heart attack.
A pharmaceutical company tested three treatments for migraine headache
sufferers. 72 participants were enrolled in the experiments. The aim is to
examine the potential of new class of treatments in lowering the pain score
associated with the migraine headache episode.
The participants include 36 males and 36 females. Males and females were
further (equally) subdivided into whether they were at low or high risk of
migraine headache.
This data set is suited for three way Anova test.
It contain the following variables:
gender, which has two
categories: "male" and "female";
risk which has two levels: "low" and
"high"
treatment, which has three categories: "X", "Y" and "Z".